As of June 2026, 2 paid clinical trials are recruiting for Lung cancer in Minneapolis, Minnesota. Lung cancer research focuses on targeted therapies for specific mutations such as EGFR, ALK, and KRAS, alongside immunotherapy regimens. Compensation typically covers time, travel, and study visits, and many studies also include study-related medical care at no cost.
Recruiting trial data synced daily from ClinicalTrials.gov. Last sync: .
Minneapolis has approximately 976 recruiting research studies across a wide range of therapeutic areas. Minnesota is anchored by Mayo Clinic in Rochester and University of Minnesota Medical Center — nationally ranked for cancer, cardiology, and rare-disease research.
Researchers run research studies in Minneapolis, MN at 50 active sites. The clinics below currently host the largest number of recruiting studies — each name is followed by the conditions they focus on most.
| Site | Specializes in | Active trials |
|---|---|---|
| University of Minnesota | Parkinson Disease, Depression, Epilepsy | 326 |
| Abbott-Northwestern Hospital | Acute Myeloid Leukemia, Stage IV Lung Cancer AJCC v8, Stage IIIB Lung Cancer AJCC v8 | 91 |
| Hennepin County Medical Center | Malignant Solid Neoplasm, Stage IV Renal Cell Cancer AJCC v8, Stage IVB Prostate Cancer AJCC v8 | 83 |
| University of Minnesota/Masonic Cancer Center | Acute Myeloid Leukemia, B Acute Lymphoblastic Leukemia, Malignant Solid Neoplasm | 43 |
| Health Partners Inc | Stage IVB Prostate Cancer AJCC v8, Malignant Solid Neoplasm, Stage IIIB Lung Cancer AJCC v8 | 41 |
| Minneapolis Heart Institute Foundation | Coronary Artery Disease, Heart Failure, Cardiovascular Diseases | 30 |
| Minneapolis VA Health Care System, Minneapolis, MN | Amputation, Bipolar Disorder, Spinal Cord Diseases | 29 |
| Children's Hospitals and Clinics of Minnesota - Minneapolis | Malignant Solid Neoplasm, Acute Myeloid Leukemia, B Acute Lymphoblastic Leukemia | 27 |
| University of Minnesota Medical Center | Aortic Stenosis, Von Willebrand Disease, Type 3, ADA SCID | 17 |
| Minneapolis Heart Institute | Aortic Stenosis, Cardiovascular Diseases, Coronary Artery Disease | 15 |
| Minneapolis VA Medical Center | Lung Non-Small Cell Carcinoma, Stage II Lung Cancer AJCC v8, Stage IIIA Lung Cancer AJCC v8 | 14 |
| Masonic Cancer Center | Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia, Adenocarcinoma of Pancreas | 13 |
| Abbott Northwestern Hospital | AMI, Acute Myocardial Infarction (AMI), Acute Stroke | 11 |
| Minneapolis VA Health Care System | Heart Failure, Aging Related Cognitive Decline, Atherosclerotic Cardiovascular Disease in Patients With ESKD | 11 |
| University of Minnesota Medical School | Niemann-Pick Type C Disease, Advanced Solid Tumor, Alopecia | 11 |
| Children's Hospitals and Clinics of Minnesota | Cystic Fibrosis, B-cell Acute Lymphoblastic Leukemia, Caregiver Burden | 10 |
| Masonic Cancer Center, University of Minnesota | Adenocarcinoma of Lung, Alcohol-Related Carcinoma, Colo-rectal Cancer | 9 |
| Children's Hospital and Clinics of Minnesota | Neuroblastoma, ALL, AML | 8 |
| M Health Fairview University of Minnesota Medical Center | Ischemic Stroke, Prostate Cancer, Adamantinomatous Craniopharyngioma | 8 |
| Hennepin Healthcare Research Institute | Acute Compartment Syndrome, Aging, Atrial Fibrillation | 7 |
| Masonic Cancer Center at University of Minnesota | Myelodysplastic Syndromes, Acute Leukemia, Acute Myeloid Leukemia | 7 |
| University of Minnesota Masonic Children's Hospital | Chronic Hepatitis B, Fabry Disease, Hypochondroplasia | 7 |
| Allina Health Cancer Institute - Abbott Northwestern Hospital | Breast Cancer, Carcinoma, Non-Small Cell Lung, Carcinoma, Non-Small-Cell Lung | 7 |
| Children's Minnesota | ALK Fusion-positive Solid or CNS Tumors, Ciliary Body Medulloepithelioma, Craniopharyngioma | 6 |
| Hennepin Healthcare | Acute Respiratory Failure, Awareness, Carcinoma, Hepatocellular | 6 |
| Allina Health | ASCVD, Acute Limb Ischemia, Acute Stroke | 5 |
| International Diabetes Center | Obesity, Type 1 Diabetes Mellitus, Chronic Kidney Disease | 5 |
| Minnesota Oncology Hematology | Breast Cancer, Cervical Cancer, Low Grade Serous Ovarian Cancer | 5 |
| Minnesota Oncology Hematology, P.A. | Breast Cancer, Advanced Breast Cancer, Carcinoma, Non-Small-Cell Lung | 5 |
| The Minnesota Cystic Fibrosis Center | Cystic Fibrosis, Cystic Fibrosis (CF), Cystic Fibrosis Lung | 5 |
| University of Minnesota Masonic Cancer Center | AML, Acquired Amegakaryocytic Thrombocytopenia, Acquired Pure Red Cell Aplasia | 5 |
| Clinical Research Institute | Acute Treatment of Migraine, Chronic Spontaneous Urticaria (CSU), Perennial Allergic Rhinitis (PAR) | 4 |
| M Health Fairview University of Minnesota Medical Center - East Bank | Heart Failure With Preserved Ejection Fraction (HFpEF), Mitral Valve Regurgitation, Neoplasms | 4 |
| Allina Health Cancer Institute | Acute Myeloid Leukemias, Bladder Cancer, Brain Cancer | 4 |
| Center for International Blood and Marrow Transplant Research | Allogeneic Stem Cell Transplantation, Autologous Stem Cell Transplantation, Blood Cancers | 3 |
| Children's Hospital of Minnesota | AVB - Atrioventricular Block, Fetal AVB, Lymphoblastic Leukemia | 3 |
| Children's Minnesota Hospital | Acute Respiratory Distress Syndrome, Extracorporeal Membrane Oxygenation, Hemolytic-Uremic Syndrome | 3 |
| Clinical Trial Site | Acid Cholesteryl Ester Hydrolase Deficiency, Type 2, Acid Lipase Deficiency, Acute Hepatic Porphyria | 3 |
| MNGI Digestive Health, PA | Crohn's Disease (CD), Liver Fibrosis, Metabolic Dysfunction Associated Steatohepatitis | 3 |
| University of Minnesota Health | Chronic Thromboembolic Pulmonary Hypertension, Dementia, Vascular, Fucosidosis | 3 |
| University of Minnesota Medical Center Fairview | Fibromyalgia, Metastatic Castration-resistant Prostate Cancer, Treatment Resistant Depression | 3 |
| Allina | Any Solid Oral Medication, Carotid Artery Diseases | 2 |
| Ascendis Investigational Site | Growth Hormone Deficiency | 2 |
| Center for Magnetic Resonance Research | Aging, Chronic Kidney Diseases, Cognition Disorders | 2 |
| GSK Investigational Site | Colonic Neoplasms, Neoplasms, Neoplasms, Colon | 2 |
| HealthPartners Medical Group | Genetic Variation, HBOC Syndrome, Hereditary Breast/Ovarian Cancer (brca1, brca2) | 2 |
| Hennepin Health | Amputation, Antibiotic Side Effect, Fracture | 2 |
| M Health Fairview Clinics and Surgery Center | Cervical Cancer, Prostate Cancer (Adenocarcinoma), mCRPC (Metastatic Castration-resistant Prostate Cancer) | 2 |
| M Health Fairview Masonic Cancer Clinic - Clinics and Surgery Center | Advanced Metastatic Castration-resistant Prostate Cancer, Advanced Non-small Cell Lung Cancer, HER2 Mutation | 2 |
| M Health Fairview Masonic Children's Hospital | Acute Respiratory Distress Syndrome, Chronic Kidney Disease, Extracorporeal Membrane Oxygenation | 2 |
Recruiting trials in Minneapolis grouped by therapeutic area, drawn from ClinicalTrials.gov. Each bucket shows the most recent example studies.
Clinical trials in Minnesota are governed by U.S. Food and Drug Administration (FDA) regulations, Office for Human Research Protections (OHRP) standards, and federal HIPAA privacy rules. Every study is reviewed by an Institutional Review Board (IRB) to protect participant safety and ensure informed consent. Minnesota research additionally follows state public health department oversight and any applicable state privacy statutes.
Hipa.ai aggregates every recruiting study in Minneapolis from ClinicalTrials.gov and refreshes the list daily. Use the filters above to narrow by condition, facility, age, phase, or healthy-volunteer eligibility, then click any study title to view full details — eligibility criteria, intervention, location, and sponsor contact information. To enroll, reach out to the central study contact listed on the study detail page; the research coordinator will walk you through the screening process.
There are approximately 976 recruiting clinical trials in Minneapolis, Minnesota listed on ClinicalTrials.gov. The number changes weekly as new studies open and others close enrollment.
Most recruiting trials in Minneapolis compensate participants for their time, travel, and study visits. Compensation varies by sponsor, study phase, and visit requirements — the exact amount is disclosed by the study team during the informed consent process.
Eligibility depends on the specific study. Each trial defines its own inclusion criteria (age, diagnosis, medical history, prior treatments) and exclusion criteria. Both patients with specific conditions and healthy volunteers can qualify, depending on the study design.
The most common conditions under active study in Minneapolis include Heart Failure (18), Acute Myeloid Leukemia (16), Breast Cancer (14), Parkinson Disease (14), among many others. Browse the list above to explore every recruiting trial.
Yes. Healthy-volunteer studies — often early-phase pharmacology or vaccine trials — recruit in Minneapolis on an ongoing basis. Use the "Healthy volunteers only" filter above to view trials that accept participants without the study's target condition.
Click any study title above to see the full study record, including eligibility criteria, visit schedule, and the study team's contact information. Reach out to the central contact or recruiting site directly — they will guide you through screening and informed consent.
Recruiting research sites in Minneapolis include University of Minnesota, Abbott-Northwestern Hospital, Hennepin County Medical Center, among others. Each site lists its open studies and contact information on the study record above — call or email the site coordinator to ask about screening for a specific protocol.
The largest active categories in Minneapolis are Cancer & tumors (269), Cardiovascular (70), Neurology & pain (59). Use the filters above to narrow by therapeutic area, phase, age, or healthy-volunteer eligibility.